Niusha Taheri, PhD Graduate Student Poster Presentation Zakk Makeiff, MSc Graduate Student Poster Presentation (Zakk, Sharon, Soto) Zakk Makeiff, MSc Graduate Student Poster Presentation (Zakk, Qian, Soto)
Metabolic and Cardiovascular Diseases Laboratory
Faculty of Agricultural, Life & Environmental Sciences
Niusha Taheri, PhD Graduate Student Poster Presentation Zakk Makeiff, MSc Graduate Student Poster Presentation (Zakk, Sharon, Soto) Zakk Makeiff, MSc Graduate Student Poster Presentation (Zakk, Qian, Soto)
A new sports drink developed in Sherwood Park hopes to do more than just quench your thirst. Austin Swiniarski is the founder and CEO of Best Hydrate and Spencer Proctor is the chief scientific officer for the brand. Click Here Read More …
2026 CLVS, September 24-27, 2026 University Faculty Club at the University of Alberta Edmonton, AB Co-Chairs: Dr. Spencer Proctor & Dr. Rene Jacobs For more info: Canadian Lipid & Vascular Summit
Thirsty? Edmonton product developers enter the sports drink market ‘This is going to be a David and Goliath story for sure’ Author of the article: By Steven Sandor Published Oct 01, 2026 Six years ago, Austin Swiniarski was close to Read More …
Watch our YouTube Video Now! Women’s Health in Focus – Part 4 PCOS in Primary Care: Case-Based Management, and Clinical Pathways: What is New? By: Drs. Mahua Ghosh, Julia Carter & Donna Vine Presented: March 24, 2026 PEARLS for Practice: Read More …
Thank you to everyone that joined & supported us at the Run for Women 2026!
Dr. Donna Vine & Dr. Yosdel Soto Lopez presented their research project findings at the CVRI Research Day, University of Alberta Hospital, Edmonton, AB, May 22, 2026.
Join our “PCOS Together & MCVD Lab Team” to participate in the Shoppers Drug Mart® Run for Women, Sir Wilfrid Laurier Park (13221 Buena Vista Rd NW, Edmonton, AB), May 23, 2026, starting at 8:30am for Team Photos. https://raceroster.com/registration/e04e364d-c3cf-49cd-ba92-a3ac133e3af8/entry?team=950834 Your registration Read More …
Polyendocrine Metabolic Ovarian Syndrome (PMOS) is the new name for the condition previously known as Polycystic Ovary Syndrome (PCOS), which impacts 1 in 8, or more than 170 million women worldwide. The new name, Polyendocrine Metabolic Ovarian Syndrome (PMOS), has Read More …
A $93.5-million commitment and 30-year collaboration is advancing research shaped by patients and improving care for families. “The gap in women’s health is a national concern, but we can be the generation that closes it,” Rutherford says, sharing a striking Read More …